Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
This study aims to evaluate the effectiveness of respiratory muscle training with COVID-19 patient, who has underlying health conditions, in order to delay or prevent them from admitting to ICU.
Description: Changes in Respiratory muscle performance will be determined by using the Respiratory Pressure Meter device. Patient will perform full inspiration through this device for 1.5 seconds via the mouth (nose occluded). The reading of the negative peak pressure that is maintained for 1 second in the device is a maximal inspiration peak.
Measure: Changes in Respiratory muscle performance Time: Baseline, 1st week, 2nd week, one monthDescription: Blood pressure measured by electronic BP machine before and after session
Measure: Blood pressure Time: Daily from baseline to hospital discharge (2 weeks)Description: measured by heart rate monitor before and after session
Measure: Heart rate Time: Daily from baseline to hospital discharge (2 weeks)Description: Measured by pulse oximeter before and after session
Measure: Oxygen saturation Time: Daily from baseline to hospital discharge (2 weeks)Description: Number of % of oxygen patient on it before and after session
Measure: Oxygen supplementation Time: Daily from baseline to hospital discharge (2 weeks).Description: measuring the number of time where the oxygen above or below 4L/min.
Measure: Oxygen flow rate Time: Daily from baseline to hospital discharge (2 weeks)Description: By using Borg scale (rating of perceived exertion scale), Possible score range from 0 (nothing) to 10 ( Maximal exertion). Before and after session.
Measure: Dyspnoea level Time: Daily from baseline to hospital discharge (2 weeks)Description: By using visual analogue scale. Possible score range from 0 (no pain) to 10 (worst possible pain) Before and after session.
Measure: Pain level Time: Daily from baseline to hospital discharge (2 weeks)Description: Measured by Respiratory rate monitor. Before and after session
Measure: Respiratory rate Time: Daily from baseline to hospital discharge (2 weeks)Description: Recording number for breath and sets daily.
Measure: Threshold IMT device Time: Daily from baseline to 1 month from admissionAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports